Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials

American Journal of Therapeutics
Nagapradeep NagajothiDaniel Benatar

Abstract

A recent meta-analysis suggested that the use of rosiglitazone increases the risk of myocardial infarction (MI) in patients with type 2 diabetes mellitus. It is unclear whether this is a class effect of thiazolidinediones (TZD). We did a meta-analysis to evaluate cardiovascular outcomes with the use of pioglitazone. Randomized, controlled trials in which pioglitazone was compared with placebo or other hypoglycemic agents were considered for analysis. Studies were included if the data for MI were available. Studies were identified with use of relevant search words in Medline, Pubmed, EMBASE, CINAHL, and Cochrane databases. Data abstraction was done by 2 individual authors using a standardized protocol. The relative risk across all study groups was computed by the Mantel-Haenszel method, and interstudy heterogeneity was assessed by the chi method. All results were computed according to 95% confidence intervals. Five trials (N = 9965) met the inclusion criteria for analysis. The relative risk for MI was 0.86 (0.69-1.07; P = 0.17). The relative risks for stroke and revascularization were 0.79 (0.61-1.02; P = 0.07) and 0.40 (0.13-1.23; P = 0.11), respectively. Pioglitazone does not increase the risk for MI and may decrease the risk ...Continue Reading

References

Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Nov 30, 2000·Biochemical and Biophysical Research Communications·J SakamotoH Sawada
Jun 26, 2001·Diabetes Care·P RaskinUNKNOWN Rosiglitazone Clinical Trials Study Group
Aug 9, 2001·Coronary Artery Disease·S RosenblattUNKNOWN Pioglitazone 026 Study Group
Jan 31, 2002·Annual Review of Medicine·Joel Berger, David E Moller
May 8, 2002·Diabetes/metabolism Research and Reviews·Francisco J Gómez-PerezErrol M Gould
May 15, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·O BarbierB Staels
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Yoshinori MiyazakiRalph A DeFronzo
Feb 5, 2003·Current Medical Research and Opinion·Varaphon VongthavaravatUNKNOWN 125 Study Group
Nov 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Katrin SchäferStavros Konstantinides
Sep 10, 2004·The New England Journal of Medicine·Hannele Yki-Järvinen
Oct 27, 2004·Archives of Internal Medicine·Elaine ChiquetteRalph Defronzo
Nov 9, 2004·International Journal of Clinical Practice·G BelcherM Valbuena
Nov 24, 2005·The Journal of Clinical Endocrinology and Metabolism·Vivian FonsecaSunil Asnani
May 31, 2006·Expert Opinion on Pharmacotherapy·Sheila A Doggrell
Nov 15, 2006·JAMA : the Journal of the American Medical Association·Theodore MazzoneSteven M Haffner
Jan 2, 2007·TheScientificWorldJournal·Emanuela EspositoRosaria Meli
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Sep 13, 2007·JAMA : the Journal of the American Medical Association·A Michael LincoffSteven E Nissen

❮ Previous
Next ❯

Citations

Oct 17, 2009·American Journal of Therapeutics·Zafar H Israili
Jun 13, 2009·Diabetes, Obesity & Metabolism·M Hanefeld
Oct 28, 2010·Diabetes, Obesity & Metabolism·G Schernthaner, R J Chilton
Aug 9, 2012·Future Cardiology·Robert P Blankfield
Jul 14, 2010·Cardiology Clinics·Sandeep A Saha, Katherine R Tuttle
Jun 9, 2016·Expert Opinion on Drug Safety·Lisa M YounkStephen N Davis
Apr 20, 2010·HIV Clinical Trials·Janet M RaboudUNKNOWN Glitazone and Lipoatrophy Meta-Analysis Working Group
Feb 25, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sylvia J Shaw, Stefan Bughi
Feb 12, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Mohsen Eledrisi
Nov 22, 2020·Current Problems in Cardiology·Lauren D BreiteBrandon E Cave
Nov 17, 2009·Journal of Proteome Research·Renato MillioniPaolo Tessari

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.